Zacks Small Cap Analysis – GRCE: Progress Report – Model Slux
By John Vandermosten, CFA NASDAQ:GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) will quickly submit its new drug utility (NDA) to the FDA, which we count on within the subsequent few weeks. The corporate not too long ago held a pre-NDA assembly with the FDA and got here away feeling intently aligned … Read more
